Klor-con and Pamidronate disodium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Klor-con (potassium chloride) and Pamidronate disodium (pamidronate disodium). Common drug interactions include pneumonia among females and atrial fibrillation among males.

The phase IV clinical study analyzes what interactions people have when they take Klor-con and Pamidronate disodium. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Klor-con?

Klor-con has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 27,547 Klor-con users. Check the latest studies of Klor-con.

What is Pamidronate disodium?

Pamidronate disodium has active ingredients of pamidronate disodium. eHealthMe is studying from 5,200 Pamidronate disodium users. Check the latest studies of Pamidronate disodium.

On Jul, 08, 2026

16 people who take Klor-con and Pamidronate disodium together, and have interactions are studied.

Klor-con and Pamidronate disodium drug interactions.

What are the common drug interactions of Klor-Con and Pamidronate Disodium, by gender? *:

female:

Pneumonia
Fluid retention (an abnormal accumulation of fluid in the blood)
Pyrexia (fever)
Body height decreased
Osteonecrosis (death of bone)
Amyloidosis (a tumour within which amyloid is produced)
Anaemia (lack of blood)
Blood creatinine increased
Bone disorder
Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)

male:

Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Cardiac failure congestive
Thrombocytopenia (decrease of platelets in blood)
Heart rate decreased
Haemorrhoidal haemorrhage (bleeding from the haemorrhoids)
Multiple myeloma (cancer of the plasma cells)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Death
Febrile neutropenia (fever with reduced white blood cells)
Haemoglobin decreased

What are the common drug interactions of Klor-Con and Pamidronate Disodium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Death
Febrile neutropenia (fever with reduced white blood cells)
Haemoglobin decreased
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Thrombocytopenia (decrease of platelets in blood)

50-59:

Osteonecrosis (death of bone)

60+:

Multiple myeloma (cancer of the plasma cells)
Anaemia (lack of blood)
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection)
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
Muscle spasms (muscle contraction)
Neck mass (mass in neck)
Oral disorder (mouth disease)
Osteomyelitis (infection of bone)
Osteonecrosis (death of bone)
Primary sequestrum (piece of dead bone that has become separated during the process of necrosis from normal/sound bone)

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 13 people, 81.25%
Constipation: 3 people, 18.75%
Seasonal Allergy (allergic condition due to certain season): 2 people, 12.50%
Oedema (fluid collection in tissue): 2 people, 12.50%
Stress And Anxiety: 1 person, 6.25%
Pain: 1 person, 6.25%
Nausea (feeling of having an urge to vomit): 1 person, 6.25%
Haemorrhoids (a swollen vein or group of veins in the region of the anus): 1 person, 6.25%
Chest Pain: 1 person, 6.25%
Breast Cancer: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Klor-con and Pamidronate disodium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously